BioSpace News Archive

Policy

Patients and Advocacy Groups File Federal Lawsuit Against the State of California to Overturn AB 290

Suit by dialysis patients, American Kidney Fund and Dialysis Patient Citizens seeks to protect thousands of low-income patients’ access to lifesaving health care [04-November-2019] ORANGE COUNTY, Calif. , Nov. 4, 2019 /PRNewswire/ -- Two kidney failure patients, together with two patient advocacy groups—the American Kidney Fund (AKF) and Dialysis Patient Citizens (DPC

November 4, 2019
·
5 min read
BioForest

NanoString Technologies Supports the Human Cell Atlas (HCA) to Enable High-plex Spatial Analysis Across Discovery Programs

A Global Collaboration with 1000+ HCA Research Institutes

November 4, 2019
·
3 min read
BioForest

NanoString Announces Availability of the GeoMx Cancer Transcriptome Atlas Through the Technology Access Program for Digital Spatial Profiling

Spatial Analysis of More Than 1,600 Key Cancer Genes from Fresh Frozen and Formalin-Fixed Paraffin-Embedded Tissue

November 4, 2019
·
3 min read
Pharm Country

Teleflex to Present at the Stephens Nashville 2019 Investment Conference

Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the Stephens Nashville 2019 Investment Conference at the Omni Nashville Hotel in Nashville, TN, on Thursday, November 14, 2019 at 9:00 a.m.

November 4, 2019
·
1 min read
Genetown

EyePoint Pharmaceuticals Announces Addition of DEXYCU® and YUTIQ® to Department of Veteran Affairs Federal Supply Schedule

DEXYCU and YUTIQ now available across the VA and on Federal Supply Schedule to benefit U.S. veterans and other government employees

November 4, 2019
·
6 min read
Business

FibroGen To Report Third Quarter 2019 Financial Results on Monday, November 11, 2019

FibroGen, Inc., announced that financial results for the third quarter 2019 will be released after market on Monday, November 11, 2019.

November 4, 2019
·
2 min read
Business

Plus Therapeutics To Report Fiscal 2019 Third Quarter Financial Results and Corporate Update on November 14, 2019

Plus Therapeutics, Inc. announced that it will report its Fiscal 2019 Third Quarter financial results after the close of market on November 14, 2019.

November 4, 2019
·
3 min read
Deals

Wright Medical Group N.V. Announces Definitive Agreement to be Acquired by Stryker

Purchase Price of $30.75 Per Share in Cash; Total Enterprise Value of Approximately $5.4 Billion and Total Equity Value of Approximately $4.7 Billion

November 4, 2019
·
10 min read
Deals

ICU Medical, Inc. to Acquire Pursuit Vascular, Inc.

Upfront purchase price is $75 million with a potential earn-out payment in 2021

November 4, 2019
·
6 min read
Biotech Beach

Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology

Halozyme Therapeutics, Inc. announced strategic actions to reposition the Company with a focus solely on its ENHANZE® drug delivery technology.

November 4, 2019
·
6 min read